CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Patient Empowerment: Combining Patient Goals of Therapy With Treatment Options in Metastatic Breast Cancer CME
Chairperson: Marnie McHale, RN, MS, AOCN; Faculty: Andrew D. Seidman, MD
Disclosures

Release Date: July 25, 2002; Valid for credit through July 23, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.



Contents of This CME Activity
  1. Empowering Breast Cancer Patients to Become Partners in Their Disease and How to Communicate Those Needs
    Empowering Patients With Breast Cancer: Introduction
    Empowering Patients to Face the Realities of Cancer
    Patient Involvement in Cancer Treatment
    The Rise in Advocacy in Patients With Breast Cancer
    Meeting the Need for Information
    Communication and Support
    Strategies for Breast Cancer Management

  2. Treatment of Hormone-Insensitive Metastatic Breast Cancer: A Patient-Physician Partnership
    Breast Cancer Chemotherapy
    Considering the Evidence on Combination Therapy
    Response and Survival Rates From Various Studies
    Dosing Options in Breast Cancer Chemotherapy
    Dose-Density
    Balancing Benefit and Harm in Breast Cancer Chemotherapy
    A Visual Perspective on Quality-of-Life Benefits
    Case Study: Taxane-Refractory Metastatic Breast Cancer
    Commonly Used Agents for Anthracycline- and Taxane-Refractory Metastatic Breast Cancer: Vinorelbine
    Commonly Used Agents for Anthracycline- and Taxane-Refractory Metastatic Breast Cancer: Capecitabine
    Commonly Used Agents for Anthracycline- and Taxane-Refractory Metastatic Breast Cancer: Gemcitabine
    Case Study: First-Line Chemotherapy for Metastatic Breast Cancer
    Studies of Human Epidermal Growth Factor Receptor 2/Neu
    Gemcitabine + Herceptin
    Capecitabine + Docetaxel
    Other Combination Chemotherapy Options Under Investigation
    Metastatic Breast Cancer: A Complex Disease and Its Management Options and Considerations

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2002 by the Oncology Education Services, Inc.
Lilly
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.